Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Small Cell Lung Carcinoma 3Retinoblastoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningeal Carcinomatosis 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1

Interventions

Cytarabine 24Busulfan 13Peripheral Blood Stem Cell Transplantation 11fludarabine phosphate 10Filgrastim 10Cyclophosphamide 10Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Mitoxantrone 7Methotrexate 7Etoposide 7Daunorubicin 7sargramostim 6Gemtuzumab 6Whole-Body Irradiation 5Radiotherapy 5tipifarnib 4alvocidib 4Azacitidine 4Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Melphalan 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Erythroblastic, Acute × trioctyl phosphine oxide × Clear all
NCT00634244 2015-07-07

Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
92 enrolled 10 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡